Related Articles
BIIB021, an Hsp90 inhibitor: A promising therapeutic strategy for blood malignancies (Review)
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review)
Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (Review)
Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells
17-ABAG, a novel geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition